Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-10-24
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Needle-Free Monitoring for IVF Patient Cycles
NCT03162809
Assessment of Two Methods for Progesterone Dosage During IVF
NCT05987657
Salivary Diagnostic Testing for IVF
NCT02040545
Progesterone Levels During Ovulation and Luteal Phase
NCT05076981
Progesterone as Luteal Support in Frozen IVF Natural Cycles
NCT04725864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IVF/FET
Progesterone analysis in saliva
Analysis of salava progesterone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progesterone analysis in saliva
Analysis of salava progesterone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* One or two good quality embryos for transfer on day 5.
* BMI \>18,5 \<30 kg/m²
Exclusion Criteria
* Uterine abnormalities
* One ovary
* Oocyte donation
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston IVF
OTHER
Peter Humaidan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Humaidan
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fertility Clinic Regional Hospital Skive
Skive, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Saliva1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.